Cerevel Therapeutics Holdings Inc

CEREStocksBiotechnologyUnited StatesNasdaqUSD

Price

$45.00

Today

+0.0%

YTD

+0.2%

About

Cerevel Therapeutics Holdings Inc designs and develops various novel therapeutics for the treatment of an array of neurological disorders globally. Cerevel Therapeutics operates within the highly innovative biotechnology sector, and has a significant role in shaping the future of neuroscientific advancement. While the firm operates independently, it has partnerships with Pfizer and Bain Capital to emphasise research and development. Notably, its range of therapeutic services targets neuroscience diseases such as Parkinson’s disease, epilepsy and schizophrenia. Explore the CERE share price and other stocks on the eToro website.

Price chart

Closing price history for CERE (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-16.46

P/S (TTM)0.00

P/B (TTM)14.49

Market cap$8.19B

Cap tierMid-cap

Industry avg P/E-6.15

Profitability

Gross marginUnknown

EBIT margin0.00%

Net marginUnknown

ROE-92.45%

ROA-44.76%

Earnings & Revenue

Revenue (TTM)$0.00

Revenue growth (1Y)Unknown

EPS (TTM)-$2.73

Free cash flow$-370.79M

Total debt$482.30M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.31

Employees334

Next earnings7 Aug '24

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.